S&P 500   2,557.02 (-98.56%)
DOW   21,648.34 (+0.05%)
QQQ   187.07 (+0.96%)
AAPL   249.90 (+0.87%)
FB   158.64 (+1.18%)
MSFT   154.72 (+3.35%)
GOOGL   1,102.97 (-0.66%)
AMZN   1,918.12 (+0.95%)
CGC   13.89 (-6.46%)
NVDA   254.39 (+0.66%)
BABA   187.60 (-0.52%)
MU   43.62 (+0.32%)
GE   7.43 (-2.49%)
TSLA   499.61 (-3.63%)
AMD   47.03 (+0.97%)
T   29.74 (-0.37%)
ACB   0.92 (-10.68%)
F   4.99 (-4.04%)
NFLX   362.83 (+1.60%)
BAC   21.45 (-0.69%)
GILD   75.58 (+3.75%)
PRI   85.67 (-3.35%)
DIS   92.93 (-3.61%)
S&P 500   2,557.02 (-98.56%)
DOW   21,648.34 (+0.05%)
QQQ   187.07 (+0.96%)
AAPL   249.90 (+0.87%)
FB   158.64 (+1.18%)
MSFT   154.72 (+3.35%)
GOOGL   1,102.97 (-0.66%)
AMZN   1,918.12 (+0.95%)
CGC   13.89 (-6.46%)
NVDA   254.39 (+0.66%)
BABA   187.60 (-0.52%)
MU   43.62 (+0.32%)
GE   7.43 (-2.49%)
TSLA   499.61 (-3.63%)
AMD   47.03 (+0.97%)
T   29.74 (-0.37%)
ACB   0.92 (-10.68%)
F   4.99 (-4.04%)
NFLX   362.83 (+1.60%)
BAC   21.45 (-0.69%)
GILD   75.58 (+3.75%)
PRI   85.67 (-3.35%)
DIS   92.93 (-3.61%)
S&P 500   2,557.02 (-98.56%)
DOW   21,648.34 (+0.05%)
QQQ   187.07 (+0.96%)
AAPL   249.90 (+0.87%)
FB   158.64 (+1.18%)
MSFT   154.72 (+3.35%)
GOOGL   1,102.97 (-0.66%)
AMZN   1,918.12 (+0.95%)
CGC   13.89 (-6.46%)
NVDA   254.39 (+0.66%)
BABA   187.60 (-0.52%)
MU   43.62 (+0.32%)
GE   7.43 (-2.49%)
TSLA   499.61 (-3.63%)
AMD   47.03 (+0.97%)
T   29.74 (-0.37%)
ACB   0.92 (-10.68%)
F   4.99 (-4.04%)
NFLX   362.83 (+1.60%)
BAC   21.45 (-0.69%)
GILD   75.58 (+3.75%)
PRI   85.67 (-3.35%)
DIS   92.93 (-3.61%)
S&P 500   2,557.02 (-98.56%)
DOW   21,648.34 (+0.05%)
QQQ   187.07 (+0.96%)
AAPL   249.90 (+0.87%)
FB   158.64 (+1.18%)
MSFT   154.72 (+3.35%)
GOOGL   1,102.97 (-0.66%)
AMZN   1,918.12 (+0.95%)
CGC   13.89 (-6.46%)
NVDA   254.39 (+0.66%)
BABA   187.60 (-0.52%)
MU   43.62 (+0.32%)
GE   7.43 (-2.49%)
TSLA   499.61 (-3.63%)
AMD   47.03 (+0.97%)
T   29.74 (-0.37%)
ACB   0.92 (-10.68%)
F   4.99 (-4.04%)
NFLX   362.83 (+1.60%)
BAC   21.45 (-0.69%)
GILD   75.58 (+3.75%)
PRI   85.67 (-3.35%)
DIS   92.93 (-3.61%)
Log in

aTyr Pharma SEC Filings & 10K Form (NASDAQ:LIFE)

$3.08
-0.17 (-5.24 %)
(As of 03/30/2020 10:06 AM ET)
Today's Range
$2.88
Now: $3.08
$3.22
50-Day Range
$2.17
MA: $3.55
$4.37
52-Week Range
$2.13
Now: $3.08
$10.08
Volume14,991 shs
Average Volume159,251 shs
Market Capitalization$11.96 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42

SEC Filings

aTyr Pharma (NASDAQ:LIFE) SEC Filings

DateFilerForm TypeView
03/26/2020
3:16 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2020
4:13 PM
aTyr Pharma (Filer)
Form PRE 14A
02/28/2020
4:16 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
1:46 PM
Altium Capital Management LP (Filed by)
aTyr Pharma (Subject)
Form SC 13G
02/12/2020
1:41 PM
aTyr Pharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/11/2020
12:27 PM
aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/11/2020
10:58 AM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:37 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:34 PM
aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
6:30 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
4:31 PM
aTyr Pharma (Filer)
Form 424B4
02/05/2020
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
02/05/2020
8:53 PM
aTyr Pharma (Filer)
Form POS EX
02/05/2020
8:48 PM
aTyr Pharma (Filer)
Form S-1MEF
02/03/2020
7:01 AM
aTyr Pharma (Filer)
Form S-1/A
01/27/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1/A
01/17/2020
7:03 AM
aTyr Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/14/2020
4:28 PM
Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G/A
01/06/2020
8:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
7:10 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
8:46 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:44 PM
aTyr Pharma (Subject)
Polaris Venture Partners V, L.P. (Filed by)
Form SC 13D/A
07/10/2019
1:58 PM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/02/2019
4:11 PM
aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2019
4:09 PM
aTyr Pharma (Issuer)
Gross Jane A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
11:15 PM
aTyr Pharma (Filer)
Form EFFECT
06/18/2019
4:28 PM
aTyr Pharma (Filer)
Form S-3/A
06/10/2019
10:51 AM
aTyr Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
05/21/2019
8:56 PM
aTyr Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/21/2019
7:45 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
7:43 PM
aTyr Pharma (Filer)
Form 424B5
05/20/2019
3:38 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
6:40 PM
aTyr Pharma (Issuer)
BLAIR JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:35 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:29 PM
aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:22 PM
aTyr Pharma (Issuer)
Hatfield Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:06 PM
aTyr Pharma (Issuer)
Coughlin Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:01 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:11 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2019
1:42 PM
aTyr Pharma (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
04/16/2019
3:57 PM
aTyr Pharma (Subject)
SCHIMMEL PAUL (Filed by)
Form SC 13D/A
04/16/2019
3:31 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
7:30 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
7:16 AM
aTyr Pharma (Filer)
Form 424B5
03/28/2019
3:15 PM
aTyr Pharma (Filer)
Form DEFA14A
03/28/2019
3:12 PM
aTyr Pharma (Filer)
Form DEFA14A
03/28/2019
3:00 PM
aTyr Pharma (Filer)
Form DEF 14A
03/26/2019
4:28 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2019
3:15 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
3:59 PM
aTyr Pharma (Filer)
Form PRE 14A
02/12/2019
3:30 PM
Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
Form SC 13G/A
02/08/2019
7:12 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
7:06 PM
aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2019
6:16 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:09 PM
aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
4:18 PM
aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
12/26/2018
3:15 PM
aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
6:12 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
3:36 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
3:38 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2018
5:12 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
3:44 PM
aTyr Pharma (Subject)
SCHIMMEL PAUL (Filed by)
Form SC 13D
09/05/2018
3:04 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
3:11 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2018
3:56 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2018
3:50 PM
aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/27/2018
8:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
7:05 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
6:29 PM
Amanullah Ashraf (Reporting)
aTyr Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
4:12 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
10:30 AM
aTyr Pharma (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
Form SC 13D/A
05/22/2018
1:39 PM
aTyr Pharma (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
05/21/2018
5:50 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
7:30 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2018
4:15 PM
aTyr Pharma (Issuer)
BLAIR JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:38 PM
aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:36 PM
aTyr Pharma (Issuer)
Nashat Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:32 PM
aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:27 PM
aTyr Pharma (Issuer)
Hatfield Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:23 PM
aTyr Pharma (Issuer)
Coughlin Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:16 PM
aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
3:05 PM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2018
4:15 PM
aTyr Pharma (Issuer)
EcoR1 Capital Fund Qualified, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
5:45 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2018
7:00 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
7:12 PM
aTyr Pharma (Issuer)
Blackburn Stan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2018
1:13 PM
aTyr Pharma (Filer)
Form CT ORDER
04/17/2018
7:31 AM
aTyr Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2018
3:10 PM
aTyr Pharma (Filer)
Form DEFA14A
04/03/2018
3:05 PM
aTyr Pharma (Filer)
Form DEFA14A
04/03/2018
3:00 PM
aTyr Pharma (Filer)
Form DEF 14A
03/23/2018
6:02 AM
aTyr Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2018
3:50 PM
aTyr Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel